S-ClassAbout S-Class
H
HOWLAI Stock Diagnostic Report
Werewolf Therapeutics stock soars 120% on Ambros merger deal
Werewolf Therapeutics' stock price surged 120% following the news of its merger agreement with Ambros.
View Source Article ↗AI CATALYST SCORE90 / 100Score computed by Sentinel V12
REFERENCE PRICE$0.4309999942779541Reference entry price at analysis time
01
MARKET SNAPSHOT
Key Indicators at a Glance
Major Support0.34 — echo this pre-calculated value verbatim, do NOT change it
Near-Term Resistance0.54 — echo this pre-calculated value verbatim, do NOT change it
02
FUNDAMENTALS
Financial & Fundamental Analysis
News of the merger agreement with Ambros has been reported, but the current stock price has plummeted 47.38% to $0.43, and the fundamental financial impact is reflected only to a limited extent.
03
TECHNICAL VIEW
Technical Position & Response Criteria
The current price of $0.43 is positioned between the 20-day low support level ($0.34) and the resistance level ($0.54), and attention should be paid to the volatility indicated by the overbought RSI (76.0).
Support0.34 — echo this pre-calculated value verbatim, do NOT change it
Resistance0.54 — echo this pre-calculated value verbatim, do NOT change it
04
CATALYST & STRATEGY
Catalyst Analysis & Forward Strategy
News of Werewolf Therapeutics' Ambros merger agreement has been reported, but since M&A is not a business plan that the company can continuously control, it will not be registered as a catalyst.
05
PROOF OF WORK
Analysis Point vs. Subsequent Price Action
INITIAL · At Analysis (2026-08-21)
FINAL · Current/Verified
Renders the actual stored OHLC data directly in your browser.